Dolutegravir (DTG) dosed according to World Health Organisation (WHO) weight bands in children weighing 10 kg to 20 kg, achieved similar concentrations to adults and...HIV/AIDS
In 2014, ViiV Healthcare, a pharmaceutical company dedicated to ending the HIV epidemic, and the Medicines Patent Pool, an organisation funded primarily by Unitaid to...HIV/AIDS
Dolutegravir (Tivicay) treatment paired with either of two tenofovir prodrugs showed non-inferior efficacy to a standard-of-care treatment regimen, MedPageToday research...HIV/AIDS
New data from the TANGO study demonstrate the non-inferior efficacy of dolutegravir/lamivudine (DTG/3TC) compared with a tenofovir alafenamide fumarate (TAF)-containing...Weekly Roundup
The US Food and Drug Administration (FDA) has approved Dovato, a new single-tablet antiretroviral regimen containing the HIV integrase inhibitor dolutegravir (sold...HIV/AIDS
Virological response rates were excellent among patients receiving second-line antiretroviral therapy (ART) based on dolutegravir, even when regimens included a...South Africa
South Africa’s recently awarded antiretroviral (ARV) tender, worth around R14bn over three years, is probably the biggest change since the single once daily tablet for...Weekly Roundup
South African drug-maker Aspen Pharmacare has launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent, reports...International
The European Medicines Agency’s risk assessment committee has recommended restrictions on the use of broad-spectrum antibiotics fluoroquinolone and quinolone following...HIV/AIDS
A large study by French researchers at CHU de Martinique, INSERM UMR 1027 - Toulouse, Nice University Hospital, Pitié Salpetrière University Hospital, Paris, Marseille...
